- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: AUPH - Aurinia Pharmaceuticals [CEO FIRED!]
Posted on 11/11/21 at 9:24 pm to bayoubengals88
Posted on 11/11/21 at 9:24 pm to bayoubengals88
It’s easy when it’s not my money. 
Posted on 11/12/21 at 12:16 pm to MSTiger33
Super low volume today compared to the last 3 weeks. Last time the volume was this low, AUPH jumped to $28 5 trading days later.
Posted on 11/12/21 at 1:35 pm to Crescent Connection
quote:Yesterday was the lowest since 10/22 rumor. Today appears to be even lower.
Super low volume today compared to the last 3 weeks. Last time the volume was this low, AUPH jumped to $28 5 trading days later.
They seem to be struggling to walk it down much lower.
I wonder how many shares are tied up, meaning unwilling to be sold. Gotta be getting pretty high. I believe the volume indicates that.
This post was edited on 11/12/21 at 2:55 pm
Posted on 11/14/21 at 2:00 pm to bayoubengals88
If there is no announcement tomorrow there might be a dip. For those with confidence that's a potential buying opportunity
Posted on 11/14/21 at 3:00 pm to molsusports
I tend to agree with an opinion I just read on StockTwits.
If BMY doesn’t announce tomorrow, they got outbid.
OR, Aurinia said “no” to 44.50, which would kinda suck.
But you’d think BMY wants Lupkynis pretty badly since they have plenty of cash, publicly stated their rheumatology needs, and terminated their Lupus Nephritis clinical trials.
If BMY doesn’t announce tomorrow, they got outbid.
OR, Aurinia said “no” to 44.50, which would kinda suck.
But you’d think BMY wants Lupkynis pretty badly since they have plenty of cash, publicly stated their rheumatology needs, and terminated their Lupus Nephritis clinical trials.
Posted on 11/14/21 at 3:37 pm to bayoubengals88
quote:
tend to agree with an opinion I just read on StockTwits.
If BMY doesn’t announce tomorrow, they got outbid.
OR, Aurinia said “no” to 44.50, which would kinda suck.
But you’d think BMY wants Lupkynis pretty badly since they have plenty of cash, publicly stated their rheumatology needs, and terminated their Lupus Nephritis clinical trials.
I'd they turned down 44.5 they are very very confident in what they have. Probably more confident than I am but I guess I see why.
Posted on 11/14/21 at 3:40 pm to bayoubengals88
I don’t see it dipping a bunch with that type offer out theee.
If they declined it, they would have clear line of aight to a lot more money
If they declined it, they would have clear line of aight to a lot more money
Posted on 11/15/21 at 9:02 am to jimjackandjose
How big do we expect this dip to be? Down 4% right now
Thinking about putting more in. Might space it out a little. Just a little weary that we’re in the same spot when we got approval and it spiked to $26 I think then bottomed and leveled at around $14
Thinking about putting more in. Might space it out a little. Just a little weary that we’re in the same spot when we got approval and it spiked to $26 I think then bottomed and leveled at around $14
This post was edited on 11/15/21 at 9:03 am
Posted on 11/15/21 at 9:27 am to jmcwhrter
thinking of an entry here.
Posted on 11/15/21 at 10:58 am to rocket31
BMY investor meeting tomorrow. I’ve taken the safety off and finger on the trigger to go full send if news leaks or here is to hoping it does.
Posted on 11/15/21 at 12:13 pm to Rendevoustavern
can't wait to see the selloff when they don't announce anything lol
Posted on 11/15/21 at 12:33 pm to Rendevoustavern
PG’s comments 2 weeks ago was more than reassuring that a BO is very imminent, wether it’s BMY or another company.
“Read in between the lines”
“May not provide guidance for 2022”
“We’re going to do everything to get this drug out to as many patients possible”
“Read in between the lines”
“May not provide guidance for 2022”
“We’re going to do everything to get this drug out to as many patients possible”
Posted on 11/16/21 at 7:50 am to Crescent Connection
He’s right you know… BO EOY $48
Posted on 11/16/21 at 8:10 am to Aug1
Did people really think BMY would walk out on stage at an investor's conference and say "HEY GUESS WHAT! We just spent $8 billion on another pharma company!"
Posted on 11/16/21 at 9:16 am to jmcwhrter
Did people really think BMY would walk out on stage at an investor's conference and say "HEY GUESS WHAT! We just spent $8 billion on another pharma company!"
Yes, people are really that desperate for a buyout. Seeking alpha had 24k searches for AUPh articles in the last 90 days and yet no news
Yes, people are really that desperate for a buyout. Seeking alpha had 24k searches for AUPh articles in the last 90 days and yet no news
Posted on 11/16/21 at 9:18 am to oklahogjr
yeah but who in the world would think BMY would announce that today?
they did, however, make it pretty well known that they have cash to spend and the most preferable path to growth is acquiring "small-to-medium sized bolt-on companies"
they did, however, make it pretty well known that they have cash to spend and the most preferable path to growth is acquiring "small-to-medium sized bolt-on companies"
Posted on 11/16/21 at 9:34 am to jmcwhrter
quote:stocktwits has all kinds of totally unhinged investment experts.
yeah but who in the world would think BMY would announce that today
quote:
they did, however, make it pretty well known that they have cash to spend and the most preferable path to growth is acquiring "small-to-medium sized bolt-on companies"
That matches narrative I've heard that pointed people to a buyout. I figure it's a lot like waiting to hear back ok a job interview. This is one of a few critical items going on and while it is appearing to take a while it's hard to know without seeing what all they have to negotiate and where they're at in the talks
Posted on 11/16/21 at 9:56 am to oklahogjr
Posted on 11/16/21 at 10:44 am to Rendevoustavern
That's getting talked about a bit by people interested in AUPH. But they have a long way to go between phase 2 and phase 3. Also keep in mind the number of drugs that make some difference but are inferior compared to the gold standard.
The A2 36 month results should be out soon. Everything through 30 months was consistent with AUPH being the standard of care.
The A2 36 month results should be out soon. Everything through 30 months was consistent with AUPH being the standard of care.
Back to top



1





